During this virtual Congressional briefing, the Congressional Personalized Medicine Caucus and the Personalized Medicine Coalition explored:

• The benefits of cell and gene therapies available and in development;
• How innovation in cell and gene therapy is challenging the United States’ health care system and its regulatory and reimbursement structures;
• How the government and private sector are trying to resolve these challenges; and
• What public policy changes are needed to promote continued innovation and patient access to cell and gene therapies.

Recording/Summary:

• Watch video recording
• Download PDF summary